Platelet Aggregation Devices Market Report 2024 - Platelet Aggregation Devices Market Growth And Trends

"The Business Research Company recently released a comprehensive report on the Global Platelet Aggregation Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp

According to The Business Research Company's, The platelet aggregation devices market size has grown exponentially in recent years. It will grow from $0.67 billion in 2023 to $0.83 billion in 2024 at a compound annual growth rate (CAGR) of 25.3%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, rising incidences of bleeding disorders, growing awareness about health diagnostics, increase in surgical procedures, improved diagnostic accuracy.

The platelet aggregation devices market size is expected to see exponential growth in the next few years. It will grow to $2.07 billion in 2028 at a compound annual growth rate (CAGR) of 25.5%. The growth in the forecast period can be attributed to growing aging population, rising demand for point-of-care testing, expansion of personalized medicine, regulatory support and approvals, increasing prevalence of chronic diseases. Major trends in the forecast period include integration of artificial intelligence in diagnostics, development of portable platelet aggregation devices, increased collaboration between biotech firms and healthcare providers, rising importance of data analytics in healthcare, shift towards home-based diagnostics.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report

Market Drivers and Trends:
The rising demand for personalized medicine is expected to propel the growth of the multiomics market going forward. Personalized medicine refers to a medical approach that customizes healthcare decisions and treatments to individual patients based on their genetic, environmental, and lifestyle factors. This personalized medicine approach is rising due to technological advancements, increasing demand for targeted therapies, and global healthcare improvements. Multiomics helps personalized medicine by providing a detailed understanding of an individual's genetic, molecular, and metabolic profile, enabling healthcare providers to tailor treatments based on the specific characteristics of each patient. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to 6 in 2022. Therefore, the rising demand for personalized medicine is driving the growth of the multiomics market.

Major companies operating in the platelet aggregation devices market are increasing their focus on developing advanced solutions by launching innovative products such as the first platelet pooling set to help stabilize the U.S. platelet supply and meet growing needs. A platelet pooling set is a specialized medical device used during plateletpheresis procedures to collect and concentrate platelets from multiple donors into a single unit for transfusion therapy. For instance, in February 2023, TERUMO BCT INC., a US-based company providing blood components and cellular technology, announced the approval of the IMUGARD WB Platelet Pooling Set by the Food and Drug Administration (FDA), a US-based federal agency. This offers extended shelf life for platelets, FDA clearance for seven-day storage, and enables platelet recoupment from whole blood donations, enhancing flexibility and availability in the platelet aggregation devices market. This launch represents a significant technological advancement by addressing the need for improved platelet availability, more efficient supply management, and supporting strained U.S. platelet supply to meet increasing demand in critical medical procedures like chemotherapy and organ transplants.

Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:
Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG & Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Drucker Diagnostics, Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago

Platelet Aggregation Devices Market 2024 Key Insights:
• The platelet aggregation devices market size is expected to see exponential growth in the next few years. It will grow to $2.07 billion in 2028 at a compound annual growth rate (CAGR) of 25.5%.
• The Increasing Incidence Of Target Diseases Is Driving The Platelet Aggregation Devices Market
• Innovative Platelet Pooling Set In The Platelet Aggregation Devices Market
• North America was the largest region in the platelet aggregation devices market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=15896&type=smp

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

This release was published on openPR.